|
|
 |
|
Viewing report
|
|
|
|
Emerging Trends in Active Pharmaceutical Ingredient Outsourcing
Pharma Answers, July 2009, Pages: 18
During the last 30 years the chemical manufacture of active pharmaceutical ingredients has been undergoing a transition from global pharmaceutical organisations back integrated to commodity chemical raw materials to organisations which focus on their key success drivers and outsource the necessary manufacturing and research support activities. This has required the development of service industries with the necessary skills, facilities and regulatory status. It has also required cultural change in the sponsor organisations and development of new techniques for project management and business risk mitigation.
This report is a review of industry news published over the last 5 years compiled into a single document to give a readily accessible overview of the trends in pharmaceutical outsourcing today.
It will be of interest to:
- Analysts studying the pharmaceutical services business sector.
- Market research professionals.
- Business development executives.
- Service industry senior managers involved in strategic decision making.
- Investors considering equity investments.
- Pharmaceutical outsourcing specialists.
The trends in active pharmaceutical ingredient outsourcing are clear. The manufacturing industry is increasing found in India with China to follow later. India has already achieved a level of sophistication in chemicals and now has biologics available too. There has been a cross flow of acquisitions in both directions between India and Europe and the US. This cross fertilisation only serves to strengthen the comfort in areas of technical capability, quality standards and protection of intellectual property. This relationship will certainly grow with some estimates being that the global pharmaceutical CRAMS industry will be worth $60 billion within the next 5 years with India in line for a large percentage. In the longer term Indian companies will emerge as new drug innovators to rival the west by which time China will have taken the mantle of world CRAMS leader.
This report has not sought to give a comprehensive report on every company engaged in pharmaceutical outsourcing in the world. Instead it is a review of industry news published over the last 5 years compiled into a single document to give a readily accessible overview of the trends in pharmaceutical outsourcing today.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
The Top 10 CMOs in India: Market Dynamics, Competitive Positioning and Trends
Indian CRAMS Industry
Industry Insight - CRAMS (Contract Research And Manufacturing Services) in India
State of the Pharmaceutical Industry, 2010 - Critical Role of Midsize Pharma
Indian Pharmaceutical Industry, Q4 2011
The Drug Discovery Outsourcing Market
Key Players in Pharmaceutical Contract Manufacturing: Market Developments, Outsourcing Hotspots and Growth Strategies
Comparisons of Pharmaceutical Manufacturing between China and India
The New Trends of Global Pharmaceutical Outsourcing: New Developments in Strategy, Market, Service and Technology
Pharmaceutical Analytical Services Outsourcing in India: Cost Savings, Product Quality and Shorter Delivery Times are Key Drivers
|
|
|
|
